| Dr Selyne Samuel, MD | |
|
2300 Miami Valley Dr Ste 350, Centerville, OH 45459-1294 | |
| (937) 424-2469 | |
| (937) 424-2479 |
| Full Name | Dr Selyne Samuel |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 13 Years |
| Location | 2300 Miami Valley Dr Ste 350, Centerville, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447538590 | NPI | - | NPPES |
| 2551671 | Other | OH | PARTNERS PHYSICIAN GROUP MEDICAID GROUP # |
| 0167456 | Medicaid | OH | |
| 1841239274 | Other | OH | PARTNERS PHYSICIAN GROUP TYPE 2 NPI # |
| 9338635 | Other | OH | PARTNERS PHYSICIAN GROUP MEDICARE GROUP # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 35-128714 (Ohio) | Secondary |
| 2086X0206X | Surgery - Surgical Oncology | 35.128714 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Miami Valley Hospital | Dayton, OH | Hospital |
| Atrium Medical Center | Franklin, OH | Hospital |
| Upper Valley Medical Center | Troy, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Specialists Inc | 5597708594 | 394 |
News Archive
The WHO "is talking with the Chinese government about sending international experts to China to help investigate a new bird flu strain that has sickened at least 24 people, killing seven of them," the Associated Press reports.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that its multicenter Phase II clinical trial with Fibrocaps in liver resection surgery resulted in a highly statistically significant 50% reduction in mean time to hemostasis (TTH) compared to active control.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluvastatin Capsules USP, 20 mg and 40 mg, the first generic version of Novartis' Lescol Capsules.
› Verified 6 days ago
| Entity Name | Premier Health Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194958223 PECOS PAC ID: 5597708594 Enrollment ID: O20050610000010 |
News Archive
The WHO "is talking with the Chinese government about sending international experts to China to help investigate a new bird flu strain that has sickened at least 24 people, killing seven of them," the Associated Press reports.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that its multicenter Phase II clinical trial with Fibrocaps in liver resection surgery resulted in a highly statistically significant 50% reduction in mean time to hemostasis (TTH) compared to active control.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluvastatin Capsules USP, 20 mg and 40 mg, the first generic version of Novartis' Lescol Capsules.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Selyne Samuel, MD 3170 Kettering Blvd, Building B 3rd Floor, Momraine, OH 45439-1924 Ph: (937) 991-3188 | Dr Selyne Samuel, MD 2300 Miami Valley Dr Ste 350, Centerville, OH 45459-1294 Ph: (937) 424-2469 |
News Archive
The WHO "is talking with the Chinese government about sending international experts to China to help investigate a new bird flu strain that has sickened at least 24 people, killing seven of them," the Associated Press reports.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
ProFibrix B.V., a leader in the development of innovative products for hemostasis, today announced that its multicenter Phase II clinical trial with Fibrocaps in liver resection surgery resulted in a highly statistically significant 50% reduction in mean time to hemostasis (TTH) compared to active control.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluvastatin Capsules USP, 20 mg and 40 mg, the first generic version of Novartis' Lescol Capsules.
› Verified 6 days ago
Adam Anthony Golas, M.D., M.P.H. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6611 Clyo Rd Ste F, Centerville, OH 45459 Phone: 937-208-5300 Fax: 937-208-2812 | |
James R Ouellette, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 2300 Miami Valley Dr, Suite 350, Centerville, OH 45459 Phone: 937-424-2469 Fax: 937-424-2479 | |
Dr. Angela Beth Echeverria, PHARM.D., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2350 Miami Valley Dr, Centerville, OH 45459 Phone: 937-438-8640 Fax: 937-438-8615 | |
Dr. Matthew P Doepker, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2300 Miami Valley Dr Ste 350, Centerville, OH 45459 Phone: 937-424-2469 Fax: 937-424-2479 | |
Dr. Andrew L Archer, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7700 Washington Village Dr Ste 130, Centerville, OH 45459 Phone: 937-531-0195 Fax: 937-531-0196 | |
Dr. Jason Thomas Hedrick, M.D, Surgery Medicare: Accepting Medicare Assignments Practice Location: 9985 Dayton Lebanon Pike, Centerville, OH 45458 Phone: 937-305-5012 Fax: 937-886-9194 |